左心房重塑参数和脑内尿素水平在非膜心房动中
Osama Amin1, Ahmed Alaarag2, Haidy Khattab3
1Department of Cardiology, Beni-Suef University, Egypt.
Journal of the Saudi Heart Association
|July 29, 2025
概括
在心力衰竭中,保留喷射分数 (HFpEF) 的心房动 (AF) 患者,低的大脑尿素 (BNP) 水平矛盾地表明严重的左心房重塑和更严重的症状. 解释BNP需要仔细考虑临床背景.
科学领域:
- 心脏病学 心脏病学
- 生物标志物 生物标志物
- 心脏成像 - - 心脏成像
背景情况:
- 左心房 (LA) 改造是心力衰竭的关键特征,具有保存的喷射分数 (HFpEF),特别是在心房动 (AF) 患者中.
- 脑性尿素 (BNP) 是一种用于评估心脏应变和LA重塑严重性的生物标志物.
- 了解HFpEF与AF中的BNP和LA体积指数 (LAVI) 之间的关系对于患者管理至关重要.
研究的目的:
- 在HFpEF患者中,与非膜AF患者相比,与鼻腔节律 (SR) 患者相比,与LAVI相关联的BNP水平.
- 评估BNP在这些患者群体中评估LA重塑的诊断影响.
- 在AF和HFpEF的背景下调查BNP解释中的潜在悖论.
主要方法:
- 一项观察性,横截面研究,涉及340名新的HFpEF患者 (140名AF,200名SR).
- 测量BNP水平并对其进行分类 (低,中等高,高).
- 使用心声回声学计算LAVI,使用斯皮尔曼相关性和多变量回归分析数据.
主要成果:
- 与SR患者相比,AF患者的BNP和LAVI水平较高.
- 矛盾的是,低BNP的AF患者显示出明显更高的LAVI和更糟糕的NYHA类症状.
- 在AF患者中发现了BNP和严重LAVI之间的负相关性,与SR患者的积极相关性形成鲜明对比.
结论:
- 矛盾的是,AF患者的HFpEF患者的低BNP水平可能表明严重的LA重塑和更糟糕的症状.
- 在HFpEF中的BNP解释需要与临床,心声和菌株数据进行整合,特别是在AF患者中.
- 考虑高BMI和病等因素对于优化这些患者的治疗很重要.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
510
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
510
01:29Heart Failure II: Pathophysiology
44
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
44
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
216
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
216